EP300 and cancer: We found that CYT scores were significantly higher in EP300-mutated than those in EP300-wild-type cancers in four cancer types, including BLCA, HNSC, STAD, and COAD (two-tailed Student’s t-test, p < 0.05) (Figure 2A).